Abstract
Ureaplasma urealyticum has been associated with urethritis in men, obstetric problems in women, and respiratory distress syndrome in preterm infants. U. urealyticum can be divided into two biovars comprising 14 serovars. Partial sequences of genes encoding the multiple-banded antigens of the cell surface are known. Using a commercially available precast DNA mutation detection gel system, we have developed a simple and reproducible PCR–single-strand conformation polymorphism analysis method for differentiating the biovars of this species that reveals five patterns among the 14 serovars and enables clinical isolates to be typed directly from broth cultures.
Ureaplasma urealyticum is a common commensal of the urogenital tract in both men and women. It has been implicated in male nongonococcal urethritis (27) and associated with a number of obstetric conditions, including chorioamnionitis and chronic respiratory distress in neonates, often with poor prognosis (1, 3). Use of polyclonal antisera raised against whole ureaplasmal cells has identifed 14 serovars (22). As shown earlier by DNA hybridization studies on serovars 1 to 8, these can be divided into two clusters or biovars. DNA homology between the biovars was less than 60% and sufficiently different to have separate species suggested for each of the biovars (5). More recently other phenotypic and genotypic traits, including results of restriction fragment analysis (7) and 16S rRNA sequencing (20), and genome size (21) have confirmed this finding. Currently, separate species status is being sought for each of the biovars (J. A. Robertson, personal communication).
Biovar 1 (parvo) consists of serovars 1, 3, 6, and 14, and biovar 2 (T960) consists of serovars 2, 4, 5, 7, 8, 9, 10, 11, 12, and 13 (22). For many years there has been speculation about the association of particular serovars with disease. For example, in one study in which the role of U. urealyticum in urinary tract disease was investigated, serotyping identified serovar 6 as the predominant type in urine samples (9). In another study, a statistical association was found between the occurrence of serovar 4 in women who had a history of recurrent abortions compared with healthy pregnant women (16). Despite these findings there has been no conclusive evidence linking a particular serovar with a disease. In part, this could reflect difficulties in interpreting serological typing results. Multiple cross-reactions are common, and clinical samples frequently contain two or more serovars that cannot casually be separated (26). Robertson et al. (19) were unable to ascribe any correlation between serovars isolated from tissues of subjects experiencing spontaneous and therapeutic abortion.
The difficulty in interpreting the results obtained in these studies was partly due to polyclonal antisera directed at the dominant antigens of the organism. A full set of set of monoclonal antibodies (MAbs) against serovar-specific antigens has recently been developed and established that polyreactivity, a disadvantage of polyclonal serotyping, was not encountered when using MAbs (6). MAbs have been used to identify multiple-banded antigens responsible for serovar specificity on the cell surface (34). Sequence variation in the genes encoding these antigens (mba genes) has been exploited to partially differentiate serovars using combinations of restriction enzymes or DNA amplification with panels of primers (12, 15, 29). However, these methods all require multistep procedures.
Single-strand conformation polymorphism (SSCP) analysis was originally developed to detect allelic variation in human genetic disorders (18). Double-stranded DNA is denatured, and the single-stranded products are separated by gel electrophoresis under accurately controlled, nondenaturing conditions. During its migration through the gel, each strand assumes a folded conformation dependent on its internal base pairing and therefore on its sequence.
The migration distances of the conformers visualized as bands on the gel are reproducible and are determined by the structure. Base substitutions or deletions can alter the conformations, causing mobility shifts in the migration patterns and revealing sequence divergence in the specific genomic region amplified. In a small (100- to 200-bp) PCR product, as little as one base change can be detected by this method (2, 4)
Although SSCP analysis has not yet found wide acceptance in bacteriology, it has been used for the detection of rifampin-resistant mutants (rpoB gene) of Mycobacterium tuberculosis (28) and to subtype Borrelia burgdorferi isolates (16S rRNA gene) (31). Bacterial 16S ribosomal DNA (rDNA) from clinical isolates has also been identified using fluorescent primers in a PCR followed by SSCP analysis in an automated DNA sequencer (30, 32).
Using commercially available precast gels in a horizontal electrophoresis system, we investigated the possibility of genotyping U. urealyticum clinical isolates from the gel patterns of single-stranded conformers of PCR-amplified products of their mba genes.
MATERIALS AND METHODS
Strains, specimens, and culture conditions.
Stock reference cultures were obtained from the American Type Culture Collection under accession numbers ATCC 27813 (serovar 1), 27814 (serovar 2), 27815 (serovar 3), 27816 (serovar 4), 27817 (serovar 5), 27818 (serovar 6), 27819 (serovar 7), 27618 (serovar 8), 33175 (serovar 9), 33699 (serovar 10), 33695 (serovar 11), 33696 (serovar 12), 33698 (serovar 13), and 33697 (serovar 14). These were maintained in the freeze-dried state and cultured in 4 ml of U4 broth (10).
Fluid clinical samples (endotracheal and nasopharyngeal aspirates) were inoculated into 2 ml of arginine-urea broth (bioMérieux, Basingstoke, United Kingdom) (24). Swabs were dipped into the broth and swirled briefly. All cultures were incubated at 37°C and inspected daily for growth.
Eighteen isolates from tissues of subjects who had experienced abortion, whose serovars had been previously established using polyclonal antiserum and a colony epifluorescence method (19, 25), were cultured in broth, and the cells were centrifuged and resuspended in 70% ethanol until the DNA was extracted. The preparations used for PCR-SSCP analyses were later passages than those used for serotyping.
DNA extraction.
Cells were harvested by centrifugation of broth cultures at 10,000 × g for 10 min. Pellets were washed twice in sterile phosphate-buffered saline (pH 7.4; Oxoid, Basingstoke, United Kingdom), resuspended by vigorously vortexing in 500 μl of sterilized Chelex 100 suspension (10%, wt/vol, in PCR quality water) (Bio-Rad, Hemel Hempstead, United Kingdom), and incubated in a 56°C water bath for 30 min. Suspensions were vortexed for 20 s, heated at 100°C for 8 min, and rapidly cooled on ice. Finally, samples were vortexed again, centrifuged at 10,000 × g for 5 min (17). The supernatants were transferred to clean tubes and stored at −20°C until required.
Amplification of mba gene fragment.
In PCR mixtures for SSCP analysis, the forward primer was UMS −120 (5′-TGCAATCTTTATATGTTTTCGTT-3′), located 120 bases upstream from the start codon of the mba sequence of serovar 3 (29). Two similar reverse primers downstream of this position were UMA +46 (5′-CCTAGTGTAATTGCTCAAAATTT-3′) and UMA +46∗ (5′-CCTAATGTCATAGCTMAGAATTT-3′), which were used together to account for degeneracies in bases in this region. Reaction mixtures (50 μl) contained 50 mM KCl, 2.5 mM MgCl2, 15 mM Tris-HCl (pH 8.0), a 200 μM concentration of each deoxyribonucleotide triphosphate, 20 pmol of each primer and 1.5 U of Taq DNA polymerase (Perkin-Elmer, Warrington, United Kingdom). Chelex extract (10 μl) was added. Samples were overlaid with oil, and 45 cycles of 95°C for 1 min, 54°C for 1 min, and 72°C for 1 min were carried out, followed by a 72°C, 10-min extension period. Reactions were performed in an Omnigene thermocycler (Hybaid, Ashford, United Kingdom).
SSCP gel electrophoresis.
To 10 μl of PCR product, 10 μl denaturing buffer (1 ml of formamide containing 0.25% bromophenol blue, mixed immediately before use with 10 μl of 1 M NaOH) was added; the mixture was vortexed briefly, heated on a PCR heating block at 95°C for 5 min, and immediately cooled on ice; and 5 μl of 50% glycerol added.
The electrophoresis system was set up 1 h before the run. An SEA 2000 tank (Elchrom Scientific, Cham, Switzerland), which possesses a buffer-circulating pump, was filled with 1.5 liters of TAE buffer (30 mM Tris-acetate, 0.75 mM EDTA buffer [pH 8.2]). The external water jacket was connected to a temperature-controlled circulating water bath.
The temperature of the circulating buffer was adjusted to 9°C before the MDA 26-lane gels (Elchrom Scientific) were placed in the tank. Before loading the samples, the buffer-circulating pump was turned off. Wells were loaded with 20 μl of ice-cold samples. Electrophoresis was carried out for 30 min at 48 V, the buffer pump was turned on, and electrophoresis continued for a further 17.5 h at 48 V. Gels were stained with SYBR gold (Molecular Probes, Leiden, The Netherlands) (1/10,000 in 10 mM TAE buffer) for 40 min, examined on a transilluminator at 254 nm, and photographed using a SYBR green filter and 667 Polaroid film.
The electrophoresis unit employed in this study enabled 26 samples, including controls to be run simultaneously. The approximate times required for processing 26 cultures were 1 h for DNA extraction, 15 min for preparation of the samples, 18 h for electrophoresis overnight, and 40 min for SYBR gold staining.
RESULTS
SSCP grouping of reference strains.
The extraction of DNA from broth culture sediments using Chelex to suppress inhibitors of Taq DNA polymerase, when applied to both standard strain cultures and clinical isolates, yielded successful PCRs. Careful control of the electrophoresis conditions allowed identification of gel banding patterns which unambiguously differentiated biovars 1 and 2 of U. urealyticum directly from the broth cultures of standard strains representing the 14 established serovars of this species and enabled placement of the serovars into five mba gene groups. A 100-bp ladder was included to estimate gel-to-gel reproducibility and does not relate to the size of the conformers, whose migration distances are based on the shape of their folded structures rather than their sequence length (Fig. 1). Biovar 1 gave a PCR product of 173 bp from which three conformer band patterns were obtained; serovars 1 and 6 gave distinct patterns, and those of serovars 3 and 14 were identical. There was less discrimination among the serovars of biovar 2, where the 217-bp product gave rise to two patterns. Pattern 2A contained serovars 2, 5, 8, and 9, and pattern 2B contained serovars 4, 7, 10, 11, 12, and 13. From these results we predicted that all isolates could be typed to one of the following mba groups: biovar 1 (1, 3/14, and 6) and biovar 2 (2A and 2B).
FIG. 1.
PCR-SSCP patterns of the reference strains of U. urealyticum used to define serovars. Lanes 1 to 14, serovars 1 to 14; lanes M, 100-bp ladder. ssDNA and dsDNA, single-stranded and double-stranded DNA, respectively.
Correlation of SSCP analysis with serotyping.
First we examined the DNA from 18 coded, previously serotyped isolates of the abortion study (19). Their biovars had been predicted based on experience with serotyping, and more recently the isolates had been typed to the biovar level by 16S rRNA gene PCRs (23). PCR-SSCP band patterns for these are shown in Fig. 2. Correlation of the biovar designation between the two types of PCR (16S rRNA and mba gene sequences) and between PCRs and the serotyping results were exact except for strain RH1139 (Table 1). On the basis of serology, RH1139, indicated as carrying serovars 11 and 13 of biovar 2, was placed in biovar 1 by both types of PCR.
FIG. 2.
PCR-SSCP patterns of serologically confirmed strains of U. urealyticum listed in Table 1. Lane 1, control serovar 1; lanes 2 to 5, RH303, RH313, RH1087, and RH872; lane 6, control serovar 3; lanes 7 to 10, RH297, RH541, RH666, and RH1139; lane 11, control serovar 6; lanes 12 to 14, RH555, RH677, and RH191; lane 15, control serovar 2; lanes 16 to 18, NIH5, T960, and RH479; lane 19, control serovar 4; lanes 20 to 23, RH122, RH507, RH539, and RH799; lane M, 100-bp ladder.
TABLE 1.
Correlation of blind-tested PCR-SSCP analysis-determined groups with biovar as determined by PCR of 16S rDNA and serovar and biovar as determined by serotyping
| Strain no. | Serovar(s) or pattern(s) as determined by:
|
||||
|---|---|---|---|---|---|
| Serotypinga
|
PCR
|
||||
| Serovar | Predicted biovar | 16S rDNAb biovar | PCR-SSCPc
|
||
| Biovar | mba gene group | ||||
| RH303 | 1 | 1 | 1 | 1 | 1 |
| RH313 | —d | — | 1 | 1 | 1 |
| RH1087 | 1 | 1 | 1 | 1 | 1 |
| RH872 | 3e | 1 | 1 | 1 | 1 |
| RH297 | 6, 13 | 1 | 1 | 1 + 2 | 6 + A |
| RH541 | 3 | 1 | 1 | 1 + 2 | 3/14 + A |
| RH666 | 3, 14 | 1 | 1 | 1 | 3/14 |
| RH1139 | 11, 13 | 2 | 1 | 1 | 6 |
| RH555 | 6 | 1 | 1 | 1 | 6 |
| RH677 | 6 | 1 | 1 | 1 | 6 |
| RH191 | 3, 6, 14 | 1 | 1 | 1 | 6 |
| NIH5 | 5 | 2 | 2 | 2 | A |
| T960 | 8 | 2 | 2 | 2 | A |
| RH479 | 4 | 2 | 2 | 2 | A + B |
| RH122 | 4 | 2 | 2 | 2 | B |
| RH507 | 13 | 2 | 2 | 2 | B |
| RH539 | 4, 13 | 2 | 2 | 2 | B |
| RH799 | 9, 12, 13 | 2 | 2 | 2 | B |
As reported by Robertson and Stemke (22).
PCR-SSCP gel pattern groups: 1, serovar 1; 3/14, serovars 3 and 14; 6, serovar 6; 2A, serovars 2, 5, 8, and 9; 2B, serovars 4, 7, 10, 11, 12, and 13.
Duplicate of RH303.
Boldface type indicates discrepant results.
For 12 of the other 17 strains, the SSCP analysis and serotyping results were in agreement. The five remaining strains did not show such clear correlation. Isolate RH872 reacted with antiserum to serovar 3 but was identified as mba gene group 1 by SSCP analysis; isolate RH799, which reacted with antisera to serovars 12 and 13 (both in biovar 2), was identified correctly as group 2B by SSCP analysis, but it also reacted with serovar 9 antiserum, which is associated with biovar 2A. Similarly, isolate RH191 reacted with antisera to serovars 3 and 14 as well as 6, but only mba gene group 6 was amplified.
From the SSCP patterns two cultures of mixed biovars (RH297 and RH541) and one (RH479) of mixed mba gene groups within a single biovar were detected. In the case of isolate RH297, serotyping resulted in reactions with antisera to serovars 6 and 13, which belong to biovars 1 and 2, respectively, and which should correlate with mba gene groups 6 and 2B. However, the SSCP analysis showed genes from each biovar but biovar 2 was associated with mba gene group 2A not 2B.
In culture RH541, both serotyping and SSCP analysis identified serovar 3, but SSCP analysis also indicated the presence of biovar 2A genes, and in RH479, for which serotyping revealed only the presence of serovar 4, equivalent to the mba gene group 2B, SSCP analysis also detected the presence of group 2A.
Application of PCR-SSCP analysis to clinical isolates.
Secondly, we subjected the deposits from 44 Ureaplasma broth culture isolates from clinical specimens to PCR-SSCP analysis in order to confirm that the five SSCP patterns would cover most isolates. These specimens were randomly selected and consisted of 15 cultures from the tracheal and nasopharyngeal aspirates of neonates, both full term and preterm, and 29 cultures from high vaginal swabs taken from pregnant and from nonpregnant woman (Table 2). All gave easily recognizable patterns that could be assigned to one of the above groups; no mixed groups were detected. All five groups were represented among the isolates.
TABLE 2.
Distribution of PCR-SSCP groups among clinical samples
| Clinical sample or group | No. of samples (n = 44) | No. of strains belonging to indicated serovars
|
||||
|---|---|---|---|---|---|---|
| Biovar 1
|
Biovar 2
|
|||||
| 1 | 3/14 | 6 | 2A | 2B | ||
| Babies (nasopharyngeal aspirates) | 15 | 1 | 5 | 4 | 2 | 3 |
| High vaginal swabs | 29 | 10 | 8 | 4 | 1 | 6 |
DISCUSSION
Genes encoding the multiple banded antigens (mba genes) of U. urealyticum have been fully sequenced for biovar 1 (serovar 3; GenBank accession no. L20329) and biovar 2 (serovar 10; GenBank accession no. U50459). The 3′ region of these genes shows marked differences in long stretches of tandem repeat units where serovar specificity is determined (34; X. Zheng, L. J. Teng, H. L. Watson, J. L. Glass, A. Blanchard, and G. H. Cassell, GenBank accession no. L20329 and U50459). Close to the 5′ end of the gene, a 45-bp deletion in the biovar 1 gene accounts for the difference in PCR product length between biovars 1 and 2 (29, 33, 34). PCRs amplifying parts of the first 400 to 500 bases of the 5′ end of the mba gene region including 125 bases upstream of the start codon followed by restriction endonuclease typing have enabled the partial differentiation of serovars into groups (29). More detailed sequence data were determined for this region for all 14 serovars by Kong et al. (15), who devised a stepwise system of biotyping and partial serovar identification based on PCR using two primer pairs and followed by restriction enzyme analysis of the products. Knox and colleagues (12, 13) have sequenced the mba 5′ regions (nucleotide positions −104 to 207) of 33 clinical isolates of U. urealyticum and compared them to the standard serovar sequences. Using a nested PCR with two outer and six inner primers, they defined nine subtypes within the biovar 1 isolates, including two subtypes of serovar 1, five of serovar 3, and two of serovar 6. Biovar 2 could be divided into two subtypes. In certain instances, the differences between subtypes of the same serovar was a single base difference. They also applied random amplified polymorphic DNA analysis (RAPD) to these isolates and, using seven primers, differentiated 13 RAPD subtypes. They concluded that RAPD provided the greatest discrimination as a typing method for U. urealyticum.
To date, significant structural and functional differences have not been identified beyond the biovar level, and neither biovars or subdivisions of them have been convincingly correlated with disease states. Unlike RAPD and restriction digest patterns of nested PCR products, PCR-SSCP analysis requires a single set of primers and a single amplification step, making it a more-efficient approach for subdividing large numbers of ureaplasmas. Groups were designated on the basis of the SSCP patterns of serovar reference strains (Fig. 1), and most of the serovars of isolates from the abortion study were broadly in agreement with their SSCP groups. The discrepant results are indicated in Table 1. One isolate (RH1139), when serotyped, belonged to biovar 2, but both 16S rDNA PCR and SSCP analysis placed it in biovar 1. The reason for this anomaly could not be explained. In two other instances where serotyping indicated mixed serovars, only one SSCP pattern was detected. These findings could represent greater precision of the SSCP analysis or changes in relative populations of subtypes in mixed cultures on later passages or the sensitivity of the methodologies.
In three instances, mixed patterns were observed on SSCP gels, but each component could clearly be identified as belonging to one of the designated groups and probably indicating mixed cultures. Although the results of gene-based methods are expected to be more easily reproducible than those of phenotyping, experience has taught us that typing cloned, laboratory-adapted strains is much easier than working with wild-type isolates (26). The serotyped isolates that were mba genotyped in this study emphasize this lesson. They had not been cloned; serotyping, biotyping, and PCR-SSCP analysis were not performed on identical cultures. All strains tested in this study provided unambiguous SSCP results, and the method could be used to group clinical isolates as shown in Table 2. However, because these were uncloned, randomly acquired isolates, we did not attempt to correlate the group designation with the pathogenic status of the patient. PCR-SSCP analysis did not detect any mixed groups among these specimens, although mixtures of serovars are commonly encountered on serotyping. In a mixed population of serovars, culture in broth could favor the growth of more-vigorous strains or those present at the highest initial density, and serotyping may reflect this. With PCR, there could be preferential amplification of the most abundant DNA template, resulting in a single group being detected.
Ideally, sequencing the mba gene would be the most accurate way of typing isolates, but it is a time-consuming, expensive, and skilled procedure and not a practical proposition for analyzing large numbers of isolates. However, PCR-SSCP analysis could be a convenient way of rapid screening prior to selecting strains for sequencing. For most diagnostic laboratories that are unable to employ sequencing, the procedure could be used routinely to analyze clinical isolates.
The two biovars of U. urealyticum can now be readily differentiated by PCRs based upon differences in the 16S rRNA (11, 23), the 16S-23S rRNA intergenic region (8), and the mba genes (29).
Genotypic methods based on the mba gene are effectively replacing the 14-member-serotyping scheme established with polyvalent antisera (12–15). Unlike MAbs, the hyperimmune sera used for serotyping may contain more than one antibody to each of the multiple antigens present in the whole-cell preparations used as immunogens. It has been shown, for instance, that many antisera contain antibodies to the biovar-specific urease enzyme (25). The infinitely greater complexity of antigen-antibody reactions compared to the variations in nucleotide sequences of a single gene means that complete correlation cannot be expected. In this study, we exploited sequence differences within the mba gene both to separate the two biovars and also to indicate subgroups consisting of one or more serovars. A single PCR will thus allow differentiation of U. urealyticum into five groups. Its application to controlled clinical studies may help to further an understanding of ureaplasmal pathogenicity. We propose that the typing of U. urealyticum strains from a wide variety of sources could be achieved more rapidly, more cheaply, and in greater numbers by this technique than by previously described methods. Direct identification of these genotypes in clinical specimens is our next goal.
ACKNOWLEDGMENT
We thank Robert C. George for constructive appraisal of the manuscript.
REFERENCES
- 1.Abele-Horn M, Wolff C, Dressel P, Pfaff F, Zimmerman A. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J Clin Microbiol. 1997;35:1199–1202. doi: 10.1128/jcm.35.5.1199-1202.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ainsworth P J, Surh L C, Coulter-Mackie M B. Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioactive method as applied to a Tay-Sachs B1 variant. Nucleic Acids Res. 1991;19:405–406. doi: 10.1093/nar/19.2.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cassell G H, Waites K B, Watson H L, Crouse D T, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev. 1993;6:69–87. doi: 10.1128/cmr.6.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chaubert P, Bautista D, Benhattar J. An improved method for rapid screening of DNA mutations by non-radioactive single-strand conformation polymorphism procedure. BioTechniques. 1993;15:586. [PubMed] [Google Scholar]
- 5.Christiansen C, Black F T, Freundt E A. Hybridization experiments with deoxyribonucleic acid from Ureaplasma urealyticum serovars I to VIII. Int J Syst Bacteriol. 1981;31:259–262. [Google Scholar]
- 6.Echahidi F, Muyldermans G, Lauwers S, Naessens A. Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates. Clin J Diagn Lab Immunol. 2000;7:563–567. doi: 10.1128/cdli.7.4.563-567.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Harasawa R, Dybvig K, Watson H L, Cassell G H. Two genomic clusters among the 14 serovars of Ureaplasma urealyticum. Syst Appl Microbiol. 1991;14:393–396. [Google Scholar]
- 8.Harasawa R, Kanamoto Y. Differentiation of two biovars of Ureaplasma urealyticum based on the 16S–23S rRNA intergenic spacer region. J Clin Microbiol. 1999;37:4135–4138. doi: 10.1128/jcm.37.12.4135-4138.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hewish M J, Birch D F, Fairley K F. Ureaplasma urealyticum serotypes in urinary tract disease. J Clin Microbiol. 1986;23:149–154. doi: 10.1128/jcm.23.1.149-154.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Howard C J, Gourlay R N, Collins J. Serological studies with bovine ureaplasma (T-mycoplasma) Int. J Syst Bacteriol. 1978;28:473–477. [Google Scholar]
- 11.Jacobs E, Vonski M, Stemke G W, Robertson J A. Identification of Ureaplasma biotypes. Med Microbiol Lett. 1994;3:31–35. [Google Scholar]
- 12.Knox C L, Giffard P, Timms P. The phylogeny of Ureaplasma urealyticum based on the mba gene fragment. Int J Syst Bacteriol. 1998;48:1323–1331. doi: 10.1099/00207713-48-4-1323. [DOI] [PubMed] [Google Scholar]
- 13.Knox C L, Timms P. Comparison of PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women. J Clin Microbiol. 1998;36:3032–3039. doi: 10.1128/jcm.36.10.3032-3039.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kong F, James G, Zhenfang M, Gordon S, Wang B, Gilbert G L. Phylogenetic analysis of Ureaplasma urealyticum: support for the establishment of a new species, Ureaplasma parvum. Int J Syst Bacteriol. 1999;49:1879–1889. doi: 10.1099/00207713-49-4-1879. [DOI] [PubMed] [Google Scholar]
- 15.Kong F, Zhu X, Wang W, Zhou X, Gordon S, Gilbert G L. Comparative analysis and serovar-specific identification of multiple-banded antigen genes of Ureaplasma urealyticum biovar 1. J Clin Microbiol. 1999;37:538–543. doi: 10.1128/jcm.37.3.538-543.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Naessens A, Foulon W, Breynaert J, Lauwers S. Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol. 1988;26:319–322. doi: 10.1128/jcm.26.2.319-322.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ochert A S, Boulter A, Birnbaum W, Johnson N W, Teo C G. Inhibitory effects of salivary fluids on PCR: potency and removal. PCR Methods Appl. 1994;3:365–368. doi: 10.1101/gr.3.6.365. [DOI] [PubMed] [Google Scholar]
- 18.Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
- 19.Robertson J A, Honore L H, Stemke G W. Serotypes of Ureaplasma urealyticum in spontaneous abortion. Pediatr Infect Dis. 1986;5:S270–S272. doi: 10.1097/00006454-198611010-00014. [DOI] [PubMed] [Google Scholar]
- 20.Robertson J A, Howard L A, Zinner C L, Stemke G W. Comparison of the 16S rRNA genes within the T960 and parvo biovars of ureaplasmas isolated from humans. Int J Syst Bacteriol. 1994;44:836–838. doi: 10.1099/00207713-44-4-836. [DOI] [PubMed] [Google Scholar]
- 21.Robertson J A, Pyle L, Stemke G W, Finch L R. Ureaplasma urealyticum shows diverse genome size by pulse-field electrophoresis. Nucleic Acids Res. 1990;18:1451–1455. doi: 10.1093/nar/18.6.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Robertson J A, Stemke G W. Expanded serotyping system scheme for Ureaplasma urealyticum strains isolated from humans. J Clin Microbiol. 1982;15:873–878. doi: 10.1128/jcm.15.5.873-878.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Robertson J A, Vekris A, Bébéar C, Stemke G W. Polymerase chain reaction using 16S rRNA sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol. 1993;31:824–830. doi: 10.1128/jcm.31.4.824-830.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sillis M. Genital mycoplasmas revisited—an evaluation of a new culture medium. Br J Biomed Sci. 1993;50:89–91. [PubMed] [Google Scholar]
- 25.Stemke G W, Robertson J A. Modified colony indirect epifluorescence test for serotyping Ureaplasma urealyticum and an adaptation to detect common antigenic specificity. J Clin Microbiol. 1981;14:582–584. doi: 10.1128/jcm.14.5.582-584.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Stemke G W, Robertson J A. Problems associated with serotyping strains of Ureaplasma urealyticum. Diagn Microbiol Infect Dis. 1985;3:311–320. doi: 10.1016/0732-8893(85)90005-7. [DOI] [PubMed] [Google Scholar]
- 27.Taylor-Robinson D, Furr P M. Genital mycoplasma infections. Wien Klin Wochenschr. 1997;109:578–583. [PubMed] [Google Scholar]
- 28.Telenti A, Imboden P, Marchesi F, Schmidheini T, Bodmer T. Direct, automated detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother. 1993;37:2054–2058. doi: 10.1128/aac.37.10.2054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Teng L-J, Zheng X, Glass J L, Watson H L, Tsai J, Cassell G H. Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene. J Clin Microbiol. 1994;32:1464–1469. doi: 10.1128/jcm.32.6.1464-1469.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Turenne C Y, Witwicki E, Hoban D J, Karlowsky J A, Kabani A M. Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single stranded conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol. 2000;38:513–520. doi: 10.1128/jcm.38.2.513-520.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Weinecke R, Koch O M, Neubert U, Göbel U, Volkenandt M. Detection of subtype-specific nucleotide sequence differences in a Borrelia burgdorferi specific gene segment by analysis of conformational polymorphisms of cRNA molecules. Med Microbiol Lett. 1993;2:239–246. [Google Scholar]
- 32.Widjojoatmodjo M N, Fluit A D C, Verhoef J. Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol. 1995;33:2601–2606. doi: 10.1128/jcm.33.10.2601-2606.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zheng X, Lau K, Frazier M, Cassells G H, Watson H L. Epitope mapping of the variable repetitive region within the MB antigen of Ureaplasma urealyticum. Clin Diagn Lab Immunol. 1996;3:774–778. doi: 10.1128/cdli.3.6.774-778.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zheng X, Teng L-J, Watson H L, Glass J L, Blanchard A, Cassell G H. Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect Immun. 1995;63:891–898. doi: 10.1128/iai.63.3.891-898.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]


